The newly signed federal funding bill marks a pivotal moment for U.S. healthcare policy by pairing short-term budget stability with long-term shifts in care delivery and drug pricing regulation. Signed into law by President Trump on February 4, the legislation extends key telehealth flexibilities, prolongs the Acute Hospital Care at Home waiver, and implements the most substantive pharmacy benefit manager (PBM) reforms to date.
With the federal government approaching yet another deadline to renew a suite of critical healthcare policies, the Medical Group Management Association’s (MGMA) January 2026 letter to congressional leadership makes clear what many in the provider space already know: temporary fixes are eroding strategic stability. From telehealth access to clinical lab reimbursement to the core viability of value-based care, the short-term extensions embedded in the latest continuing resolution reflect a dangerous pattern of legislative hesitation at precisely the moment long-term certainty is most needed.
Improper payments across federal healthcare programs continue to absorb tens of billions of taxpayer dollars each year, posing a persistent operational risk that too often escapes strategic scrutiny. The Centers for Medicare & Medicaid Services (CMS) has released its Fiscal Year 2025 estimates, revealing a complex and often misunderstood picture of payment accuracy, documentation failures, and structural compliance breakdowns.
Revenue cycle teams are operating under sustained pressure. Patient financial responsibility keeps climbing, staffing shortages make manual outreach harder to maintain, and organizations are fighting to prevent revenue leakage at every step of the patient journey. Yet much of the communication that underpins collections still depends on time-consuming phone calls, letters, and portals that patients either ignore or struggle to access.
With a $3.5 billion valuation and more than 50 enterprise clients, Hippocratic AI has rapidly positioned itself as a category leader in patient-facing healthcare agents. Its $126 million Series C round, led by Avenir Growth Capital and supported by major health systems including WellSpan Health, Universal Health Services, and Cincinnati Children’s Hospital Medical Center, reflects more than investor confidence.
The recent 200 percent year-to-date surge in Tempus AI stock has captured the attention of investors, traders, and technology analysts alike. But the true implications of Tempus’s momentum stretch well beyond technical indicators and price targets.
More than 700 rural hospitals in the United States are at risk of closure. That figure is a systems-level indicator that current reimbursement structures, staffing models, and administrative expectations are fundamentally misaligned with the operating realities of small, low-margin health facilities.
UnitedHealth Group’s July 31 announcement that Wayne DeVeydt will succeed John Rex as chief financial officer caps a turbulent six-month stretch punctuated by a profit warning, the return of founding leader Stephen Hemsley, and a dramatic retreat from Medicare Advantage (MA).
Revenue cycle automation strategy now defines resilience in healthcare finance under mounting regulatory, payer, and labor pressures. As reimbursement models shift and payer behaviors change frequently, health systems are under increasing pressure to embed automation within governance, compliance, and forecasting frameworks. Technology adopted without strategic rigor risks backfiring.
The new strategic partnership between Ensemble Health Partners and Methodist Le Bonheur Healthcare (MLH) marks a decisive turn in the healthcare industry’s approach to revenue cycle management (RCM). It is an operational realignment built on a belief that revenue cycle functions are now too complex, too tech-driven, and too strategic to remain fragmented or under-resourced.
Revenue cycle automation has moved beyond operational efficiency to become a core strategic asset for health systems navigating financial instability. With hospitals facing heightened pressure from staffing shortages, contract variability, and rising patient financial responsibility, the demand for intelligent automation in revenue cycle management (RCM) is now a structural imperative.
Readmission penalties have turned the quiet hours after discharge into the most expensive minutes on the hospital balance sheet. Leadership teams that once viewed patient portals as convenience tools must now treat mobile engagement platforms as critical infrastructure for value-based payment survival.
Revenue cycle platforms such as JanusIQ gained initial traction by correcting upstream inefficiencies in authorization and claims workflows. The true test, however, lies in navigating regulatory enforcement, vendor competition, and long-term enterprise integration. This follow-up editorial analyzes those emerging pressures and the decisions revenue leaders must now anticipate.
Best Buy has sold Current Health back to co-founder Christopher McGhee, ending a US$400 million retail foray and returning operational control of roughly one-third of national hospital-at-home episodes to the company’s original leadership. The transaction, confirmed by Home Health Care News(homehealthcarenews.com), reunites McGhee with fellow co-founder Stewart Whiting and several early engineers whose platform once powered remote acute care for Mass General Brigham and Atrium Health.
One week after the rollout of Altera Digital Health’s Sunrise 25.1, the conversation has shifted from feature analysis to strategic implications. This release redefines how health systems should evaluate their electronic health record (EHR) vendors, not just for functionality, but for alignment with performance-linked, modular modernization.
We use cookies and similar technologies to improve your experience on our website.
This website uses cookies and similar technologies. They are grouped into categories, which you can review and manage below. If you have accepted any non-essential cookies, you can change your preferences at any time in the settings.
These technologies are required to activate the core functionality of our website.
These technologies allow our website to remember your preferences and provide you with a more personalized experience.
These technologies enable us to analyse the use of our website in order to measure and improve performance.
These technologies are used by our marketing partners to show you personalized advertisements relevant to your interests.